| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.31 | 0.05 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |